Cargando…
Galectin‐3 Is Elevated and Associated With Adverse Outcomes in Patients With Single‐Ventricle Fontan Circulation
BACKGROUND: Galectin‐3 may play a role in cardiac and noncardiac fibrosis, and elevated circulating levels of this protein predict adverse outcomes in patients with heart failure who do not have congenital heart disease. We investigated galectin‐3 in adults with single‐ventricle Fontan circulation,...
Autores principales: | Opotowsky, Alexander R., Baraona, Fernando, Owumi, Justin, Loukas, Brittani, Singh, Michael N., Valente, Anne Marie, Wu, Fred, Cheng, Susan, Veldtman, Gruschen, Rimm, Eric B., Landzberg, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859390/ https://www.ncbi.nlm.nih.gov/pubmed/26755550 http://dx.doi.org/10.1161/JAHA.115.002706 |
Ejemplares similares
-
Hepatic Steatosis in Patients With Single Ventricle and a Fontan Circulation
por: Katz, David A., et al.
Publicado: (2021) -
Occult Diastolic Dysfunction and Adverse Clinical Outcomes in Adolescents and Young Adults With Fontan Circulation
por: Peck, Daniel, et al.
Publicado: (2022) -
Thromboembolic Events Are Independently Associated with Liver Stiffness in Patients with Fontan Circulation
por: Alsaied, Tarek, et al.
Publicado: (2020) -
Myocardial fibrosis, diastolic dysfunction and elevated liver stiffness in the Fontan circulation
por: Alsaied, Tarek, et al.
Publicado: (2020) -
Fontan Liver Lesions: Not Always HCC
por: Haeffele, Christiane, et al.
Publicado: (2019)